Alto Neuroscience, Inc. (ANRO)
NYSE: ANRO · Real-Time Price · USD
20.30
+0.28 (1.40%)
Mar 24, 2026, 12:57 PM EDT - Market open

Alto Neuroscience Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
176.48168.2382.5548.3425.71
Cash & Short-Term Investments
176.48168.2382.5548.3425.71
Cash Growth
4.91%103.79%70.75%88.07%-
Accounts Receivable
----1.5
Other Receivables
---0.33-
Total Trade Receivables
---0.331.5
Other Current Assets
1.231.112.840.540.48
Total Current Assets
177.72169.3485.3949.2227.68
Net Property, Plant & Equipment
6.137.71.111.171.06
Other Long-Term Assets
0.840.50.130.460.05
Total Assets
184.69177.5486.6350.8528.79
Accounts Payable
1.881.581.071.610.6
Accrued Expenses
8.868.434.543.951.21
Current Portion of Long-Term Debt
0.59----
Total Current Liabilities
11.3310.015.615.561.81
Long-Term Debt
16.1710.259.869.47-
Long-Term Leases
3.824.52---
Other Long-Term Liabilities
2.231.31.3521.3
Total Long-Term Liabilities
22.2216.0711.2111.471.3
Total Liabilities
33.5526.0816.8217.033.11
Common Stock
00---
Additional Paid-in Capital
352.75289.955.372.30.49
Accumulated Other Comprehensive Income
0.02-0.1-0.08-0.05-0.02
Retained Earnings
-201.63-138.4-76.97-40.66-12.95
Total Common Shareholders' Equity
151.14151.46-71.67-38.41-12.48
Minority Interest
--141.4872.2438.16
Shareholders' Equity
151.14151.4669.8133.8325.69
Total Liabilities & Equity
184.69177.5486.6350.8528.79
Total Debt
20.5814.779.869.470
Net Cash (Debt)
155.9153.4672.6938.8825.71
Net Cash Growth
1.59%111.12%86.96%51.25%-
Net Cash Per Share
5.406.2419.4811.2810.65
Book Value
151.14151.46-71.67-38.41-12.48
Book Value Per Share
5.246.16-19.21-11.15-5.17
Tangible Book Value
151.14151.46-71.67-38.41-12.48
Tangible Book Value Per Share
5.246.16-19.21-11.15-5.17
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q